|
OMIM |
Link |
Information gain |
01 |
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
0.00282061
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.00137383
|
|
|
sitosterolemia
|
[NCBI]
|
0.00090183
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000847142
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000767896
|
|
|
wolman disease
|
[NCBI]
|
0.000636576
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000586906
|
|
|
LDLR
|
[NCBI]
|
0.000343369
|
|
|
ARH
|
[NCBI]
|
0.000243445
|
|
|
CYP27A1
|
[NCBI]
|
0.000177385
|
|
|
APOE
|
[NCBI]
|
0.000155072
|
|
|
ABCG8
|
[NCBI]
|
0.000125082
|
|
|
wolman disease with hypolipoproteinemia and acanthocytosis
|
[NCBI]
|
0.000118781
|
|
|
LDLRAP1
|
[NCBI]
|
0.000106707
|
|
|
LPL
|
[NCBI]
|
0.000106365
|
|
|
ALGS1
|
[NCBI]
|
9.13247e-05
|
|
|
C3
|
[NCBI]
|
8.24269e-05
|
|
|
cardiomyopathy, infantile histiocytoid
|
[NCBI]
|
7.50102e-05
|
|
|
SLE
|
[NCBI]
|
7.26564e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
6.99932e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
5.63538e-05
|
|
|
SOAT1
|
[NCBI]
|
5.06447e-05
|
|
|
APOA1
|
[NCBI]
|
3.02141e-05
|
|
|
PG
|
[NCBI]
|
2.43272e-05
|
|
|
DFSP
|
[NCBI]
|
1.65775e-05
|
|
|
LCAT
|
[NCBI]
|
1.58509e-05
|
|
|
ALD
|
[NCBI]
|
8.94511e-06
|
|
|
APOB
|
[NCBI]
|
8.17332e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
7.47621e-06
|
|
|
GFAP
|
[NCBI]
|
7.0139e-06
|
|
|
CEACAM5
|
[NCBI]
|
7.25477e-07
|
|